Back to Search Start Over

POSC108 Estimated Hospitalization-Related Costs with Oral Azacitidine (ORAL-AZA) vs. Placebo for Remission Maintenance in Patients with Acute Myeloid Leukemia (AML) in Sweden and Norway.

Authors :
Porkka, K
Oliva, E
Skikne, B
Beach, C
Zhong, J
Ranjan, S
Potluri, R
Jalan, H
Chen, C
Source :
Value in Health. 2022 Supplement, Vol. 25 Issue 1, pS108-S108. 1p.
Publication Year :
2022

Details

Language :
English
ISSN :
10983015
Volume :
25
Issue :
1
Database :
Academic Search Index
Journal :
Value in Health
Publication Type :
Academic Journal
Accession number :
154761808
Full Text :
https://doi.org/10.1016/j.jval.2021.11.513